{"id":"https://openalex.org/W1980614347","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","title":"Abstract IA14: Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4.","display_name":"Abstract IA14: Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1980614347","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","mag":"1980614347"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.tumimm2012-ia14","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071033599","display_name":"Padmanee Sharma","orcid":"https://orcid.org/0000-0003-4658-055X","observed_orcids":["https://orcid.org/0000-0003-4658-055X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Padmanee Sharma","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071033599"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"1_Supplement","first_page":"IA14","last_page":"IA14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9110000133514404},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.6359999775886536},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9409999847412109},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.843999981880188},{"id":"https://openalex.org/keywords/foxp3-regulatory-t-cells","display_name":"Foxp3+ regulatory T cells","score":0.847000002861023},{"id":"https://openalex.org/keywords/ny-eso-1","display_name":"NY-ESO-1","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cancer-testis-antigens","display_name":"cancer-testis antigens","score":0.7609999775886536},{"id":"https://openalex.org/keywords/b16f10-melanoma","display_name":"B16F10 melanoma","score":0.8859999775886536},{"id":"https://openalex.org/keywords/costimulation","display_name":"costimulation","score":0.597000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.621999979019165},{"id":"https://openalex.org/keywords/leuprolide-acetate","display_name":"leuprolide","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8519009351730347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.790269136428833},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6320542097091675},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5018255710601807},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47915738821029663},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47051042318344116},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.46709153056144714},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.45930561423301697},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4565562307834625},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.44136449694633484},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.42462027072906494},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.42407214641571045},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40072304010391235},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3968588709831238},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.38442501425743103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3795620799064636},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3737865388393402},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.36962369084358215},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.26694512367248535},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.20718011260032654},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10805898904800415},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.tumimm2012-ia14","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-ia14","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2038464832","https://openalex.org/W2141756397","https://openalex.org/W2275214567","https://openalex.org/W2155101465","https://openalex.org/W1981528932","https://openalex.org/W1621831367","https://openalex.org/W7095797496","https://openalex.org/W2144995154","https://openalex.org/W2157041114","https://openalex.org/W2966365908"],"abstract_inverted_index":{"Abstract":[0],"Biomarker":[1],"studies":[2],"used":[3,244],"with":[4,49,57,71,78,182,225,249,265,328,353],"immunotherapeutic":[5],"strategies":[6],"in":[7,52,76,164,247,286,294,296],"the":[8,17,44,65,140,192,203,211,263,272,297,308,318,344,359],"clinic":[9],"have":[10],"typically":[11],"involved":[12],"monitoring":[13],"immunologic":[14],"changes":[15,26],"within":[16,27,122,307],"systemic":[18],"circulation;":[19],"however,":[20],"recent":[21],"data":[22,41,83],"indicate":[23],"that":[24,135,161,205,260,278],"immunological":[25],"tumor":[28,91,123,146],"tissues":[29,92,124],"will":[30],"be":[31],"more":[32,269],"likely":[33],"to":[34,190,201,251,321,333],"predict":[35],"clinical":[36,47],"responses.":[37],"To":[38,216],"obtain":[39],"such":[40],"we":[42,219],"conducted":[43],"first":[45,66],"pre-surgical":[46,69],"trial":[48,70],"anti-CTLA-4":[50,167,183,195,214,250,266,276],"(ipilimumab)":[51],"a":[53,155,177,187,226,231,292,313,348],"cohort":[54],"of":[55,101,110,117,125,154,157,194,207,213,262,279,301,330,358],"patients":[56,77],"localized":[58,79],"bladder":[59],"cancer.":[60,81],"We":[61,96,148,258],"are":[62,87,172],"also":[63],"conducting":[64],"combination":[67,248,261,351],"therapy":[68,352],"ipilimumab":[72],"plus":[73,275],"leuprolide":[74],"acetate":[75],"prostate":[80],"Immunological":[82],"from":[84,89],"these":[85],"trials":[86],"obtained":[88],"both":[90,176],"and":[93,103,114,138,237,243,299,303,370],"blood":[94],"samples.":[95],"found":[97,259],"an":[98],"increased":[99,163],"frequency":[100,116,165],"CD4":[102,119,302],"CD8":[104,304],"T":[105,120,133,159,170,305],"cells":[106,121,134,160,171,224,235,240,306],"expressing":[107],"high":[108],"levels":[109],"inducible":[111],"costimulator":[112],"(ICOS)":[113],"decreased":[115],"FOXP3-expressing":[118],"treated":[126],"patients.":[127],"The":[128,284],"CD4+ICOShi":[129],"population":[130],"contained":[131],"effector":[132,158],"produced":[136],"IFN-\u03b3":[137],"recognized":[139],"cancer-testis":[141],"antigen":[142],"NY-ESO-1":[143],"expressed":[144],"on":[145,363],"cells.":[147],"therefore":[149],"identified":[150],"ICOS":[151,208],"as":[152,175,184,186,347],"marker":[153,179],"subset":[156],"is":[162],"after":[166],"therapy.":[168,196,215],"ICOS+":[169],"being":[173],"explored":[174],"pharmacodynamic":[178],"for":[180,316,350],"treatment":[181,282],"well":[185],"novel":[188,314],"target":[189,349],"improve":[191],"efficacy":[193,212,288],"These":[197,310],"observations":[198],"led":[199],"us":[200],"test":[202],"possibility":[204],"engagement":[206],"could":[209],"enhance":[210,322,334],"this":[217],"end":[218],"transduced":[220],"mouse":[221],"B16F10":[222,256],"melanoma":[223],"cDNA":[227],"encoding":[228],"ICOSL":[229],"or":[230,246,277],"control":[232,238,273],"construct.":[233],"B16-ICOSL+":[234],"(IVAX)":[236],"B16":[239],"were":[241],"irradiated":[242],"alone":[245],"treat":[252],"mice":[253],"bearing":[254],"established":[255],"tumors.":[257],"IVAX":[264],"was":[267,289],"markedly":[268],"effective":[270],"than":[271],"vaccine":[274],"any":[280],"single":[281],"alone.":[283],"increase":[285,295],"therapeutic":[287],"accompanied":[290],"by":[291,337],"marked":[293],"density":[298],"functionality":[300],"tumor.":[309],"results":[311],"suggest":[312],"strategy":[315],"manipulating":[317],"immune":[319],"system":[320],"anti-tumor":[323],"responses:":[324],"checkpoint":[325],"blockade":[326],"coupled":[327],"provision":[329],"agonist":[331],"signals":[332],"costimulation":[335],"mediated":[336],"ICOS.":[338],"Citation":[339],"Format:":[340],"Padmanee":[341],"Sharma.":[342],"Investigating":[343],"ICOS/ICOSL":[345],"pathway":[346],"anti-CTLA-4.":[354],"[abstract].":[355],"In:":[356],"Proceedings":[357],"AACR":[360],"Special":[361],"Conference":[362],"Tumor":[364],"Immunology:":[365],"Multidisciplinary":[366],"Science":[367],"Driving":[368],"Basic":[369],"Clinical":[371],"Advances;":[372],"Dec":[373],"2-5,":[374],"2012;":[375],"Miami,":[376],"FL.":[377],"Philadelphia":[378],"(PA):":[379],"AACR;":[380],"Cancer":[381],"Res":[382],"2013;73(1":[383],"Suppl):Abstract":[384],"nr":[385],"IA14.":[386]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}